HWM
SBIO icon

HighMark Wealth Management’s ALPS Medical Breakthroughs ETF SBIO Stock Holding History

HighMark Wealth Management’s Portfolio SBIO Stock Details SBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-850
Closed -$23.1K – 599
2023
Q3 		$23.1K Buy
850
+100
+13% +$3.01K 0.02% 163
2023
Q2 		$23.7K Hold
750
– – 0.02% 168
2023
Q1 		$20.4K Buy
750
+200
+36% +$6.04K 0.02% 208
2022
Q4 		$16.7K Hold
550
– – 0.01% 186
2022
Q3 		$17K Hold
550
– – 0.01% 184
2022
Q2 		$15K Buy
550
+150
+38% +$4.28K 0.01% 199
2022
Q1 		$13K Hold
400
– – 0.01% 228
2021
Q4 		$17K Buy
+400
New +$17.8K 0.01% 193

Other funds holding SBIO

DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
NAM
NTV Asset Management Charleston, West Virginia $910M AUM 27.02% 1-Year Est. Return
SFS
Strategic Financial Services Utica, New York $2.1B AUM 19.14% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
GS
GTS Securities New York $2.83B AUM 21.76% 1-Year Est. Return

HighMark Wealth Management's SBIO Position: Q4 2023 in Review

HighMark Wealth Management sold out of ALPS Medical Breakthroughs ETF (SBIO) in Q4 2023, closing a stake of 850 shares — an estimated $23.1K sold.

HighMark Wealth Management first reported a position in SBIO in Q4 2021 and held it in 8 quarters. The position peaked at $23.7K in Q2 2023. 34 funds tracked by Wall St. Rank hold SBIO as of Q4 2023.

  • HighMark Wealth Management reported no remaining ALPS Medical Breakthroughs ETF position as of Q4 2023 after selling out during the quarter.
  • HighMark Wealth Management sold 850 ALPS Medical Breakthroughs ETF shares in Q4 2023, an estimated $23.1K.
  • HighMark Wealth Management first reported a position in ALPS Medical Breakthroughs ETF in Q4 2021 and held it in 8 quarters.
  • HighMark Wealth Management's ALPS Medical Breakthroughs ETF position peaked at $23.7K in Q2 2023.
  • 34 funds tracked by Wall St. Rank held ALPS Medical Breakthroughs ETF as of Q4 2023.

Based on HighMark Wealth Management's 13F filing for Q4 2023, filed 23 Jan 2024.